Publications by authors named "David Turnquist"

Claim this Profile
A
A Phase 1 Safety Study of Evexomostat (SDX-7320) in Patients with Late-Stage Cancer: An Antiangiogenic, Insulin-Sensitizing Drug Conjugate Targeting METAP2.
Monica M Mita, Alain C Mita, Bradley J Carver, James M Shanahan, Benjamin A Mayes, David J Turnquist

Cancer Res Commun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity.
Peter Cornelius, Benjamin A Mayes, John S Petersen, David J Turnquist, Pierre J Dufour

Mol Cancer Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Pharmacokinetics, Biotransformation and Elimination of Pomotrelvir Orally Administered in Healthy Male Adults Using Two [C]-Labeled Microtracers with Separate Labeling Positions.
Ziping Yang, Shekman L Wong, David Cha, David Wilfret, David Turnquist

Drug Metab Dispos· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities.
Farrukh Vohidov, Jannik N Andersen, Kyriakos D Economides, Michail V Shipitsin, Olga Burenkova, David J Turnquist

J Am Chem Soc· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic Activity of the Novel Neurokinin-3 Receptor Antagonist SJX-653 in Healthy Men.
Richard A Anderson, Jennifer Cormier, Ruth Thieroff-Ekerdt, Malcolm Boyce, Frans van den Berg, David Turnquist

J Clin Endocrinol Metab· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Phase I Evaluation of CTP-499, a Novel Deuterium-Containing Drug Candidate for Diabetic Nephropathy.
Virginia Braman, Philip Graham, Changfu Cheng, David Turnquist, Mark Harnett

Clin Pharmacol Drug Dev· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vision correction with excimer lasers.
David V Turnquist

Conf Proc IEEE Eng Med Biol Soc· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis